Navigation Links
Nobles Medical Technologies II Receives US Patent for “Suturing and Method” for its NobleStitch Technology
Date:9/13/2013

Fountain Valley, California (PRWEB) September 13, 2013

Nobles Medical Technologies II today announced that it has received another US Patent for its NobleStitch Technology. The patent is for the Device and Method of our suturing technology. This patent shows the broad coverage of our method as used throughout the entire body and all biological tissue.

Prof. Dr. Anthony Nobles, CEO of NMT2 and co-inventor on the issued patent commented, “Intellectual property is one of the most valuable assets we have, in the medical device industry patents represent one of the greatest measurements of the value of the company. This patent carry’s broad coverage for all of our applications for our technology and is a critical piece of our portfolio.”

Ben Brosch, President of NMT2 and co-inventor on the issued patent commented, “We strive to protect our inventions with strong patents that help us protect our technology. We continuously file new patents and have grown an extensive portfolio of patents and trademarks adding value to our company and its shareholders”.

About Patent Foramen Ovale (PFO)
A PFO is a tunnel that exists between the left and right atrium of the heart. The tunnel, which is part of the normal fetal anatomy, should close shortly after birth. In 27% of the population the tunnel never closes. This tunnel can then allow clots and other chemicals to pass from the right to the left side of the heart freely bypassing the filter of the lungs. These clots and chemicals can cause strokes and other conditions such as severe migraines.

About the NobleStitch EL System
Nobles Medical Technologies II's NobleStitch EL is a catheter based system that allows a physician to place a suture in the PFO tunnel in the heart through a percutaneous puncture in the leg, in many cases under a local anesthetic in a catheter lab rather than an operating room. This eliminates the need for open-heart surgery or placement of a large metallic implant in the heart. The NobleStitch is not a “device” or mechanical implant it only places a simple polypropylene suture in the heart. By closing the hole or PFO, the therapy will reduce or eliminate the shunting from the right to the left side of the heart allowing the lungs to filter the clots and other chemicals from making it to the brain, potentially halting strokes and severe migraines and enabling patients to live a higher-quality life.

About Nobles Medical Technologies II
Nobles Medical Technologies II is a global structural heart company devoted to improving life through the development of its products and technologies. Nobles Medical Technologies II is focused on suture based solutions for the septum. The NobleStitch is available in Europe and is undergoing and IRB study for specific indication in the US. The NobleStitch has CE mark for “Cardiovascular suturing and PFO closure” and US FDA 510k clearance for “vascular suturing”

Visit Nobles Medical Technologies II http://www.noblesmedicaltechnology.com

Read the full story at http://www.prweb.com/releases/2013/9/prweb11118545.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Nobles Medical Technologies II's NobleStitch EL Receives Strong Reviews from Physicians at Congenital & Structural Interventions Congress (CSI) in Frankfurt
2. Nobles Medical Technologies II's NobleStitch EL begins Sales in Europe
3. Boston Medical Center Wins the $100,000 Drucker Award for Nonprofit Innovation
4. North Shore Eye Care Adds Ophthalmologists Lawrence Buono, MD Christine Speer-Buono, MD To Medical Staff
5. Diet Doc Medical Weight Loss Plans Now Offers Body Fat Burning Best Diet Pills Without Having to Travel to a Local Weight Loss Clinic
6. InventHelp® Client Develops Better Medical Valve (DVR-579)
7. 1 Focus Medical Software Offering Promotional Discount for Dragon Medical Practice Edition 2
8. Diet Doc Announces Improved Medical Diet Plans That Help Patients Avoid Excess Weight Gain, Now Found to Possibly be Caused by Antidepressant Medication
9. InnerVision Medical Technologies Develops Ultrasound Device to Image Morbidly Obese
10. Discount Medical Supplies Launches a Mobile Version to Help Customers Place Orders on the Go
11. Medical Device Manufacturing in China Industry Research Report – Now Available from IBISWorld
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... During the last week of March, Chad Kawa, ... eligible individuals in the local community. , Colon cancer is the second leading ... colon cancer while it is small, confined and easier to treat. If you are ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up to 36% ... other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors ... finding more effective treatment options, the San Diego Gamma Knife Center offers ...
(Date:3/29/2017)... Atlanta, Georgia (PRWEB) , ... March 29, 2017 , ... ... Theresa Therilus, founder of Pet Protect Law that assists dog owners in ... will assist new owners in taking the natural next step to protect their new ...
(Date:3/29/2017)... ... ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS , BALTIMORE WOMEN’S CLASSIC ... as the official title sponsor of the Baltimore Women’s Classic, the largest all women’s ... will walk or run the course around the Baltimore Inner Harbor. Mercy has been ...
(Date:3/29/2017)... ... , ... Sublime Naturals and its founder, Kathy Heshelow, are big fans of ... used for thousands of years. , "The West has caught on, and has discovered ... to Use it For Your Wellness. Overcome Inflammation, Enemy of the Body. " ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... -- P rogressed to commercial ... Vergenix™STR distribution and sales agreements in Europe ... 3D bioInk , the Company , s ... for 3D printing of human organs and tissue   P ... in specific indications in 2017   CollPlant (TASE: ...
(Date:3/30/2017)... 30, 2017  Boston Scientific Corporation (NYSE: ... Symetis SA, a privately-held Swiss structural heart company focused ... million in up-front cash. The Symetis portfolio includes ... * systems for use in the treatment of ... stenosis, which are sold in Europe ...
(Date:3/30/2017)... , March 30, 2017 Stock-Callers.com ... in the research, development, and production of non-electronic medical, surgical, ... are: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Co. (NYSE: ... Inc. (NYSE: BCR ). Download the free research ... ...
Breaking Medicine Technology: